Am J Transplant, Volume 17, Suppl 3 Archives - Page 57 of 181 - ATC Abstracts

2017 American Transplant Congress
BK Polyomavirus-Specific 9mer T-Cell Responses Predict Control of Viremia in Kidney Transplant Recipients: First Report from the Swiss Transplant Cohort Study.
H. Hirsch,¹ C. Leboeuf,¹ S. Wilk,¹ R. Achermann,² I. Binet,³ D. Golshayan,² K. Hadaya,² C. Hirzel,² M. Hoffmann,² U. Huynh-Do,² M. Koller,² O. Manuel,² N. Mueller,² T. Mueller,² S. Schaub,² C. Van Delden,² F. Weissbach.¹
¹University of Basel, Basel, Switzerland; ²Swiss Transplant Cohort Study, Basel, Switzerland; ³Cantonal Hospital St Gallen, St Gallen, Switzerland
BK polyomavirus (BKPyV) causes premature kidney transplant (KT) failure in 1-15% of patients. Since antivirals are lacking, most programs screen KT patients for BKPyV viremia…
2017 American Transplant Congress
Effects of Liver Transplantation on Cardiac Function in Patients Transplanted for NASH Cirrhosis.
H. Maddur, L. VanWagner, D. Gregory, B. Wodzinski, K. Maganti, M. Rinella.
Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
Nonalcoholic Steatohepatitis (NASH) is independently associated with increased cardiovascular events after liver transplantation (LT). NASH is also associated with subclinical myocardial dysfunction in the general…
2017 American Transplant Congress
Expression of T-Cell Mediated Rejection (TCMR) Associated Genes in Native and Renal Allograft Renal Biopsies with Inflamed Scars (i-IFTA).
Z. Lyu,¹ L. Pang,¹ G. Zeng,² Y. Huang,² P. Randhawa.²
¹Pathology & Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China; ²Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA
The presence of i-IFTA in allograft kidney biopsies is a bad prognostic parameter. However, despite the presence of T-cell infiltrates in these lesions there is…
2017 American Transplant Congress
Ex-Situ Extended Limb Preservation: A Protocol for Porcine Limb Perfusion.
E. Dalla Pozza,¹ E. Duraes,¹ M. Madajka,¹ R. Frautschi,¹ K. Cho,¹ N. Dawlagala,¹ V. Fahradyan,¹ H. Shah,¹ C. Cakmakoglu,¹ C. Quintini,² F. Papay,¹ A. Rampazzo,¹ B. Bassiri Gharb.¹
¹Plastic Surgery, Cleveland Clinic, Cleveland, OH; ²General Surgery, Cleveland Clinic, Cleveland, OH
Background: Ischemia and reperfusion injury remains a significant limiting factor for the success of vascularized composite allotransplantation. Compared to the cold storage of the procured…
2017 American Transplant Congress
Meta-Analysis of Clinical Significance of Complement Activating Anti-HLA DSA in Kidney Transplantation.
A. Bouquegneau,^1,2 C. Ulloa,¹ O. Aubert,¹ C. Loheac,¹ D. Viglietti,¹ J. Empana,¹ P. Jabre,¹ X. Jouven,¹ C. Lefaucheur,¹ A. Loupy.¹
¹Paris Translational Research Center for Organ Transplantation, Paris, France; ²Department of Nephrology, Dialysis and Transplantation, Liège, Belgium
Donor-specific anti-HLA antibodies (DSA) are currently recognized as the major limitation to access transplantation and the first cause of late transplant failures. The effect of…
2017 American Transplant Congress
Podocyte Participates in the ST2 Related Renal Fibrosis.
Y. Kim,¹ S. Yang,^2,3 R. Cha,⁴ M.-Y. Yu,¹ S. Lee,³ H. Lee,¹ J. Lee,⁵ D. Kim,^1,3 S. Kim,³ Y. Kim.^1,2,3
¹Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; ²Seoul National University Biomedical Research Institute, Seoul, Republic of Korea; ³Kidney Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; ⁴Internal Medicine, National Medical Center, Seoul, Republic of Korea; ⁵Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea
Objective Soluble ST2 (sST2) which is the receptor of IL-33 is involved in renal inflammation and it is also correlated with disease severity in chronic…
2017 American Transplant Congress
Assessment and Transplantation of Declined Human Kidneys Using Ex-Vivo Normothermic Kidney Perfusion.
S. Hosgood,¹ M. Hamed,¹ A. Sawpaul,² R. Figueiredo,² K. Saeb-Parsy,¹ C. Wilson,² M. Nicholson.¹
¹Department of Surgery, University of Cambridge, Cambridge, United Kingdom; ²Transplantation, Transplant Institute, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
PurposeThe aim of this study was to make more kidneys available for transplantation by using ex-vivo normothermic kidney perfusion (EVKP) technology to assess the quality…
2017 American Transplant Congress
Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis.
M. Lim,¹ D. Sawinski,¹ J. Cohen,^1,2 B. Weiss,^3,4 J. Hogan,^1,3 L. Dember.^1,3
¹Renal, Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, PA; ²Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; ³Penn Amyloidosis Program, Division of Hematology-Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; ⁴Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
Background: Data on patient and graft outcomes of kidney transplant recipients with end stage renal disease (ESRD) from systemic amyloidosis is scarce. Methods: We performed…
2017 American Transplant Congress
Stable Deceased Donor Transplantation Rates Among Pediatric Candidates Post-KAS Implementation.
B. Shelton,¹ C. Ray,¹ D. Sawinski,² R. Reed,¹ P. MacLennan,¹ J. Locke.¹
¹University of Alabama at Birmingham, Birmingham; ²University of Pennsylvania, Philadelphia
Background: The Kidney Allocation System (KAS) was implemented in December 2014 and increased access to deceased donor kidney transplant (DDKT) for highly sensitized candidates. Concerns…
2017 American Transplant Congress
Living Kidney Donors: Battling High Attrition Rates During Evaluation Process.
J. Verbesey, A. Bacigalupo, A. Gilbert, A. Li, C. Zuttermeister, M. Grafals, J. Moore, B. Javaid, P. Abrams, S. Ghasemian, M. Cooper.
MedStar Georgetown Transplant Institute, Washington DC
With an ever increasing kidney waiting list, a major goal is to expand living donor transplantation (LD). LD increases volume and provides higher quality, longer…